-
161
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
162
Leveraging mRNA technology for antigen based immuno-oncology therapies
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
163
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
Published 2021-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
164
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
165
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports
Published 2019-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
166
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
167
CAR T-cell detection scoping review: an essential biomarker in critical need of standardization
Published 2023-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
168
Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
169
CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
170
Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
171
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
172
T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint pr...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
173
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or ade...
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
174
Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article